{"id":"W4206244400","doi":"10.5489/cuaj.7074","title":"2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC) (full-text)","year":2021,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; Université Laval; Canadian Urological Association; University of Alberta; Jewish General Hospital; McMaster University; Ontario Clinical Oncology Group; Dalhousie University; University of Toronto; McGill University Health Centre; University of British Columbia","funders":"Ipsen; Astellas Pharma; Bavarian Nordic; Eisai; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Guideline; Prostate cancer; Medicine; Oncology; Internal medicine; Castration; Gynecology; Cancer; Urology; Family medicine; Hormone; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004422422,0.001041178,0.001906662,0.004189234,0.00179654,0.003368898,0.004159839,0.008755368,0.05375556],"category_scores_gemma":[0.03366087,0.0008855116,0.002483702,0.004886899,0.0009768603,0.001612554,0.001309974,0.007111442,0.02790907],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0109778,"about_ca_system_score_gemma":0.05111592,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4084219,"about_ca_topic_score_gemma":0.6628269,"domain_scores_codex":[0.9938709,0.001132236,0.0009641018,0.0002561231,0.003241005,0.0005357055],"domain_scores_gemma":[0.9657171,0.003616155,0.001374843,0.00023537,0.02693996,0.002116702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008697833,0.000008548715,0.00009701659,0.0005455473,0.00001187858,0.00002262521,0.00001079263,0.0000351863,0.00002947362,0.0002433147,0.9851404,0.0138465],"study_design_scores_gemma":[0.0001266404,0.00002283451,0.002069271,0.006712076,0.0001066226,0.0001510959,0.00005121177,0.0001360712,0.00006358145,0.0007804642,0.989744,0.00003616979],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.001293045,0.1205069,0.004648032,0.4150605,0.07825793,0.005621979,0.09355676,0.0008684655,0.2801864],"genre_scores_gemma":[0.01302999,0.2508099,0.03850618,0.2937656,0.03620052,0.005349983,0.1458947,0.0007373857,0.2157058],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9890222,"threshold_uncertainty_score":0.8120892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02185939494072469,"score_gpt":0.3026939838313087,"score_spread":0.280834588890584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}